$AVNI
ARVANA INC Stock $avni

$avni Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000160706223000201 Filed on April 17, 2023

Income Statement

Concept	2023 Q2	2022 Q4	2022
Revenue	$13.58K	$0.00	$0.00
YoY Change
Cost Of Revenue	$14.63K	$29.71K	$29.71K
YoY Change
Gross Profit	-$1.050K	-$29.71K	-$29.71K
YoY Change
Gross Profit Margin	-7.73%
Selling, General & Admin	$108.7K	$64.53K	$136.1K
YoY Change	588.78%	140.34%	32.54%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.851K		$0.00
YoY Change
% of Gross Profit
Operating Expenses	$123.3K	$64.53K	$165.8K
YoY Change	681.53%	140.34%	61.47%
Operating Profit	-$109.7K	-$94.24K	-$165.8K
YoY Change	595.44%		61.46%
Interest Expense	$16.52K	$20.00	$587.00
YoY Change	4104.33%	-122.22%	-104.7%
% of Operating Profit
Other Income/Expense, Net	-$4.522K		$14.44K
YoY Change	-130.96%		-100.12%
Pretax Income	-$114.3K	-$94.22K	-$151.4K
YoY Change	9633.39%	249.87%	-98.75%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$114.3K	-$94.22K	-$151.4K
YoY Change	9633.3%	249.87%	-98.75%
Net Earnings / Revenue	-841.51%
Basic Earnings Per Share	$0.00		$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	35.95M shares	35.95M shares	34.60M shares
Diluted Shares Outstanding	107.8M shares		34.60M shares

Balance Sheet

Concept	2023 Q2	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.65K	$142.4K
YoY Change	41.29%	4162.57%
Cash & Equivalents	$18.65K	$142.4K
Short-Term Investments
Other Short-Term Assets	$5.100K	$0.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$23.75K	$142.4K
YoY Change	80.0%	4162.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$167.0K	$0.00
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$193.0K	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$23.75K	$142.4K
Total Long-Term Assets	$193.0K	$0.00
Total Assets	$216.8K	$142.4K
YoY Change	1542.71%	4162.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$67.17K	$37.87K
YoY Change	152.89%	-31.06%
Accrued Expenses	$53.77K	$29.77K
YoY Change	2050.84%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$38.19K	$0.00
YoY Change
Total Short-Term Liabilities	$130.4K	$37.87K
YoY Change	4.47%	-63.91%
LONG-TERM LIABILITIES
Long-Term Debt	$887.7K	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$887.6K	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$130.4K	$37.87K
Total Long-Term Liabilities	$887.6K	$0.00
Total Liabilities	$1.018M	$37.87K
YoY Change	715.82%	-63.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$37.28M	-$36.24M
YoY Change	3.28%	0.42%
Common Stock	$36.49M	$36.35M
YoY Change	1.37%	0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.336K	$3.336K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$801.3K	$104.5K
YoY Change
Total Liabilities & Shareholders Equity	$216.8K	$142.4K
YoY Change	1542.71%	4162.43%

Cashflow Statement

Concept	2023 Q2	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$114.3K	-$94.22K	-$151.4K
YoY Change	9633.3%	249.87%	-98.75%
Depreciation, Depletion And Amortization	$5.851K		$0.00
YoY Change
Cash From Operating Activities	-$55.17K	-$70.82K	-$132.7K
YoY Change	408.95%	476.71%	295.03%
INVESTING ACTIVITIES
Capital Expenditures			$0.00
YoY Change
Acquisitions			$0.00
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.27K	-820.0	$271.7K
YoY Change	6.45%	-105.26%	750.85%
NET CHANGE
Cash From Operating Activities	-55.17K	-70.82K	-$132.7K
Cash From Investing Activities	0.000	0.000	$0.00
Cash From Financing Activities	22.27K	-820.0	$271.7K
Net Change In Cash	-32.90K	-71.64K	$139.0K
YoY Change	-426.39%	-2257.83%	-8525.76%
FREE CASH FLOW
Cash From Operating Activities	-$55.17K	-$70.82K	-$132.7K
Capital Expenditures			$0.00
Free Cash Flow			-$132.7K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001113313
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	0-30695
CY2022	dei	Entity Registrant Name EntityRegistrantName	ARVANA INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-0618509
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	299 Main Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	13th Floor
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Salt Lake City
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84111
CY2022	dei	City Area Code CityAreaCode	(801)
CY2022	dei	Local Phone Number LocalPhoneNumber	232-7395
CY2022	dei	Security12g Title Security12gTitle	Common Stock, $0.001 par value
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	10550590	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	35948518	shares
CY2022	dei	Auditor Name AuditorName	DAVIDSON & COMPANY LLP
CY2022	dei	Auditor Location AuditorLocation	Canada
CY2022	dei	Auditor Firm AuditorFirmId	731
CY2022	dei	Auditor Firm AuditorFirmId	731
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	142365	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	3340	usd
CY2022Q4	us-gaap	Assets Assets	142365	usd
CY2021Q4	us-gaap	Assets Assets	3340	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	29770	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	54931	usd
CY2022Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	0	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	15500	usd
CY2022Q4	AVNI	Due To Related Party Current DueToRelatedPartyCurrent	8100	usd
CY2021Q4	AVNI	Due To Related Party Current DueToRelatedPartyCurrent	34494	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	37870	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	104925	usd
CY2022Q4	us-gaap	Liabilities Liabilities	37870	usd
CY2021Q4	us-gaap	Liabilities Liabilities	104925	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	35948518	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35948518	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34148518	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34148518	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	35949	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	34149	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36312250	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	35956574	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36240368	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36088972	usd
CY2022Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	107831	usd
CY2021Q4	us-gaap	Stockholders Equity Before Treasury Stock StockholdersEquityBeforeTreasuryStock	-98249	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2085	shares
CY2021Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2085	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3336	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3336	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	104495	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-101585	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	142365	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3340	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	70432	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15608	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	29713	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	65686	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	87096	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	165831	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	102704	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-165831	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-102704	usd
CY2022	us-gaap	Interest Income Operating InterestIncomeOperating	22	usd
CY2021	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
CY2022	us-gaap	Interest Expense InterestExpense	587	usd
CY2021	us-gaap	Interest Expense InterestExpense	19207	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	0	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	6708	usd
CY2022	AVNI	Loss On Debt Settlements LossOnDebtSettlements	0	usd
CY2021	AVNI	Loss On Debt Settlements LossOnDebtSettlements	-12460079	usd
CY2022	us-gaap	Other Income OtherIncome	15000	usd
CY2021	us-gaap	Other Income OtherIncome	458833	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14435	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12013744	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12116448	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34603463	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17188600	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.68
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34603463	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	17188600	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.68
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2051060	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	14065923	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-12116448	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-101585	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	320000	usd
CY2022	AVNI	Share Issuance Cost ShareIssuanceCost	-32237	usd
CY2022	AVNI	Conversion Of Related Party Debt To Equity ConversionOfRelatedPartyDebtToEquity	40000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29713	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-151396	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	104495	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-12116448	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-587	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-19207	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-0	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	21852	usd
CY2022	AVNI	Loss From Debt Settlements LossFromDebtSettlements	-0	usd
CY2021	AVNI	Loss From Debt Settlements LossFromDebtSettlements	-12460079	usd
CY2022	AVNI	Other Income Amount OtherIncomeAmount	15000	usd
CY2021	AVNI	Other Income Amount OtherIncomeAmount	458833	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	29713	usd
CY2021	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	0	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-2061	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	43787	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	5506	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	40481	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-132651	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33579	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022	AVNI	Share Capital ShareCapital	320000	usd
CY2021	AVNI	Share Capital ShareCapital	0	usd
CY2022	AVNI	Proceeds Of Loans Payable ProceedsOfLoansPayable	0	usd
CY2021	AVNI	Proceeds Of Loans Payable ProceedsOfLoansPayable	31925	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	15500	usd
CY2021	us-gaap	Payments For Loans PaymentsForLoans	-0	usd
CY2022	us-gaap	Interest Paid InterestPaid	587	usd
CY2021	us-gaap	Interest Paid InterestPaid	-0	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	32237	usd
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	-0	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	271676	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31925	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	139025	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1654	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3340	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4994	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	142365	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3340	usd
CY2022	AVNI	Debt Forgiveness Included In Amounts Due To Related Parties Accounts Payable And Accrued Liabilities Note8 DebtForgivenessIncludedInAmountsDueToRelatedPartiesAccountsPayableAndAccruedLiabilitiesNote8	15000	usd
CY2021	AVNI	Debt Forgiveness Included In Amounts Due To Related Parties Accounts Payable And Accrued Liabilities Note8 DebtForgivenessIncludedInAmountsDueToRelatedPartiesAccountsPayableAndAccruedLiabilitiesNote8	458833	usd
CY2022	AVNI	Conversions Of Related Party Debt To Equity ConversionsOfRelatedPartyDebtToEquity	40000	usd
CY2021	AVNI	Conversions Of Related Party Debt To Equity ConversionsOfRelatedPartyDebtToEquity	0	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zaZ8cJVTj91b" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86B_zx1zXv8WgeUb">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. These estimates include the recognition of deferred tax assets based on the change in unrecognized deductible temporary tax differences.</span></p>
CY2022Q4	us-gaap	Cash Cash	142365	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zDmltLzsnEUb" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_868_zuV2IDfWsT38">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash. The Company maintains cash in bank accounts that, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank account.</span></p>
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-151396	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2650000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-36240368	usd
CY2022Q4	AVNI	Working Capital WorkingCapital	104495	usd
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	29713	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2650000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2650000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.28
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	1600000	shares
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.20
CY2022Q4	AVNI	Restricted Common Stock Total Proceeds RestrictedCommonStockTotalProceeds	320000	usd
CY2022	AVNI	Incurred Share Issuance Costs IncurredShareIssuanceCosts	32237	usd
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	29537848	shares
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.48
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	14065923	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	752944	usd
CY2021Q4	us-gaap	Convertible Debt ConvertibleDebt	107800	usd
CY2021Q4	us-gaap	Other Loans Payable OtherLoansPayable	390267	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	74762	usd
CY2021Q4	AVNI	Due To Related Party Current And Noncurrent DueToRelatedPartyCurrentAndNoncurrent	149124	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	12460079	usd
CY2022Q4	AVNI	Loans Payable To Stockholders LoansPayableToStockholders	0	usd
CY2021Q4	AVNI	Loans Payable To Stockholders LoansPayableToStockholders	15500	usd
CY2022	us-gaap	Interest Expense Borrowings InterestExpenseBorrowings	587	usd
CY2021Q4	AVNI	Loan Settled Through Issuance Of Common Shares LoanSettledThroughIssuanceOfCommonShares	6740	usd
CY2021Q4	AVNI	Interest Settled Through Issuance Of Common Shares InterestSettledThroughIssuanceOfCommonShares	5920	usd
CY2021Q4	AVNI	Common Shares Issued For Settlement Of Debt CommonSharesIssuedForSettlementOfDebt	26507	shares
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	178526	usd
CY2021	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	343233	usd
CY2021Q4	AVNI	Common Share Issued For Settlement Of Loan CommonShareIssuedForSettlementOfLoan	24402624	usd
CY2022Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	7500	usd
CY2022Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	600	usd
CY2022Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	40000	usd
CY2021Q4	AVNI	Loan Payable To Related Party LoanPayableToRelatedParty	130947	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	89124	usd
CY2021	us-gaap	Extinguishment Of Debt Gain Loss Net Of Tax ExtinguishmentOfDebtGainLossNetOfTax	12650	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4938	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	23150	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	38915	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-107079	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Other Income OtherIncome	15000	usd
CY2021	us-gaap	Other Income OtherIncome	458833	usd
CY2021	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	206302	usd
CY2021Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	163586	usd
CY2021	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	88945	usd
CY2022Q4	AVNI	Convertible Loans Outstanding ConvertibleLoansOutstanding	0	usd
CY2021Q4	AVNI	Convertible Loans Outstanding ConvertibleLoansOutstanding	0	usd
CY2021Q3	AVNI	Common Shares With Fair Value CommonSharesWithFairValue	172480	usd
CY2021Q3	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	25768	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.2491	pure
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-151396	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	12116448	usd
CY2022	AVNI	Income Tax Reconciliation Computed Expected Tax Expense Benefit IncomeTaxReconciliationComputedExpectedTaxExpenseBenefit	-37714	usd
CY2021	AVNI	Income Tax Reconciliation Computed Expected Tax Expense Benefit IncomeTaxReconciliationComputedExpectedTaxExpenseBenefit	-3018268	usd
CY2022	AVNI	Income Tax Reconciliation Income Nondeductible Expenses IncomeTaxReconciliationIncomeNondeductibleExpenses	3737	usd
CY2021	AVNI	Income Tax Reconciliation Income Nondeductible Expenses IncomeTaxReconciliationIncomeNondeductibleExpenses	3102197	usd
CY2022Q4	AVNI	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	235321	usd
CY2021Q4	AVNI	Deferred Tax Assets Startup Costs DeferredTaxAssetsStartupCosts	196402	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	235321	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	196402	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	939825	usd
CY2021	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	788429	usd

Files In Submission

Name	View Source	Status
0001607062-23-000201-index-headers.html	Edgar Link	pending
0001607062-23-000201-index.html	Edgar Link	pending
0001607062-23-000201.txt	Edgar Link	pending
0001607062-23-000201-xbrl.zip	Edgar Link	pending
avni-20221231.xsd	Edgar Link	pending
avni123123form10k.htm	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
avni-20221231_cal.xml	Edgar Link	unprocessable
avni-20221231_def.xml	Edgar Link	unprocessable
avni-20221231_pre.xml	Edgar Link	unprocessable
avni-20221231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avni123123form10k_htm.xml	Edgar Link	completed
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVNI
ARVANA INC Stock $avni

2023 Q2 Form 10-K Financial Statement

#000160706223000201 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNI ARVANA INC Stock $avni

2023 Q2 Form 10-K Financial Statement

#000160706223000201 Filed on April 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVNI
ARVANA INC Stock $avni